Ditchcarbon
  • Contact
  1. Organizations
  2. Genovac GmbH
Public Profile
Pharmaceutical Preparation Manufacturing
DE
updated 2 months ago

Genovac GmbH Sustainability Profile

Company website

Genovac GmbH, headquartered in Germany, is a leading player in the biotechnology industry, specialising in the development and production of high-quality nucleic acids and proteins. Founded in 2001, the company has established itself as a trusted partner for research institutions and pharmaceutical companies across Europe and beyond. With a focus on custom oligonucleotides, plasmid DNA, and RNA products, Genovac stands out for its commitment to precision and quality. The company’s state-of-the-art facilities and innovative technologies enable it to deliver tailored solutions that meet the specific needs of its clients. Recognised for its expertise and reliability, Genovac GmbH continues to strengthen its market position, contributing significantly to advancements in genetic research and therapeutic development.

DitchCarbon Score

How does Genovac GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Genovac GmbH's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Genovac GmbH's reported carbon emissions

Genovac GmbH, headquartered in Germany, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions, including Scope 1, 2, and 3, are not provided. Furthermore, there are no documented reduction targets or climate pledges from Genovac GmbH at this time. The company has not cascaded any emissions data from a parent or related organization, indicating that they operate independently in terms of climate reporting. In the absence of specific emissions data and reduction initiatives, it is unclear how Genovac GmbH is addressing climate commitments within the industry context.

How Carbon Intensive is Genovac GmbH's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Genovac GmbH's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Genovac GmbH's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Genovac GmbH is in DE, which has a medium grid carbon intensity relative to other regions.

Genovac GmbH's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Genovac GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Genovac GmbH's Emissions with Industry Peers

Evotec

DE
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Abveris Inc.

US
•
Chemicals nec
Updated about 1 month ago

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 11 hours ago

Sartorius

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Wuxi Apptec

CN
•
Research and development services (73)
Updated 8 days ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251215.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy